Hemab Therapeutics has concluded an oversubscribed Series C funding round, raising $157m to further develop therapies for ...

MSD has received US FDA approval for an updated indication of Winrevair by injection to treat adults with pulmonary arterial ...

A sales probe from Organon's board has found evidence of wholesaler sales malpractice, resulting in Ali's resignation and a ...

Real-world data (RWD) is an asset for vaccine research, safety monitoring, and education efforts, and is essential toward ...

Guardant Health and Zephyr AI have partnered to advance the discovery of novel cancer biomarkers, as more precise tumour ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

Eli Lilly has agreed to acquire eye disease specialist Adverum Biotechnologies, bucking a recent trend of big pharma ...

Novartis has signed an agreement for the acquisition of all the outstanding shares of US-based Avidity Biosciences.

Chugai has signed a definitive stock agreement to purchase Japan-based Renalys Pharma, augmenting its kidney disease ...

Zavodnick told Pharmaceutical Technology that Excellergy plans to initiate an ex-US Phase I study of its lead ECRI candidate, a monoclonal antibody, in Q1 2026, with the goal of being ready for Phase ...

A report by GlobalData revealed that the biotech industry witnessed a 70.9% increase in total venture financing deal value.

BioCryst Pharmaceuticals has signed a definitive agreement to buy Astria Therapeutics with a mix of cash and stock ...